The Elephants Are the Easy Part. The Twenty Kilometres Are Not.

Eighty bicycles went out across one Zimbabwean province, and more than 22,000 girls were vaccinated against cervical cancer. The barrier was never mainly doubt. It was twenty kilometres of dirt road — and the people who ride it may not be paid this month.

Arnold Sita is thirty-seven and he rides a bicycle for a living, except that nobody calls it a living, because the pay is an allowance and the allowance is not guaranteed. His route runs through Kariba, one of the hottest and driest districts in Zimbabwe, where the thorn trees drop spikes that go through a tyre without slowing down and the baobabs attract animals that outweigh a car. The animals do not worry him much. "We know the wild elephants," he told the health journalist Tsitsi Bhobo earlier this year. "We grew up around them, and we deftly don't disturb them as we pursue the mission."

The mission is a vaccine against cervical cancer, carried house to house, to girls who would otherwise never be offered it.

Village health workers in Kariba and neighbouring Hurungwe have become known locally as vaccine cyclists. Eighty bicycles went out across Mashonaland West province, paid for by Zimbabwe's Ministry of Health together with UNICEF and the Clinton Health Access Initiative. In the two years since, more than 22,000 girls in the province have been immunised against human papillomavirus. The workers ride in groups of roughly thirteen and cover their villages weekly. They talk in Tonga and Shona rather than in the language of the pamphlet. Once a month they come back to a clinic, where a nurse or a doctor goes over the biology with them again, so that whatever is being said about the vaccine in the village that week, they can answer it without guessing.

Zimbabwe recorded an estimated 3,520 new cervical cancer cases in 2023, and about two thirds of the women diagnosed are expected to die of the disease. The vaccine blocks more than nine in ten of the infections that cause it. National HPV coverage sits at roughly 55 per cent, and the missing 45 per cent is not scattered evenly across the map. It sits where the average household is twenty kilometres from the nearest hospital.

Twenty kilometres. That is the figure the coverage statistics never show.

Blame the road, not the rumour

When vaccination numbers are low, the reflex diagnosis is doubt. Misinformation, hesitancy, rumour — all of it exists, and Kariba has seen its share. It is also the diagnosis that flatters everyone holding a budget, because the implied cure is a campaign, and a campaign can be commissioned without leaving the capital city.

The problem in Kariba was never mainly doubt. It was the dirt road between the district hospital and the girl. A vaccine that has cleared regulators on three continents, that has been financed, procured and kept cold the whole way to a district store, still has to travel that last stretch, and for most of the last century of public health that final leg has been the leg nobody pays for. Here somebody finally paid. The payment was eighty bicycles.

On 11 September, India's health minister J.P. Nadda announced that the national HPV campaign had passed eight million doses since its launch in February, and the WHO's director-general called it proof of what political commitment can do. Across Africa the number of countries delivering the vaccine has almost tripled since 2019, from eleven to thirty-one, with coverage climbing from 18 to 47 per cent by the end of 2024. The figures are real and hard-won. They also stop at a district store, where a woman with a cool box decides whether she is willing to ride.

Underneath the bicycle there is a piece of laboratory science that deserves credit for making the ride possible at all. A randomised trial in Kenya, KEN SHE, found a single dose of HPV vaccine to be 97.5 per cent effective against the two viral types responsible for most cervical cancer, statistically indistinguishable from the multi-dose schedules it was tested against. WHO's vaccine advisory group adopted a one-or-two-dose option at the end of 2022 on that evidence. For a woman on a bicycle the difference is not academic. One dose means one ride, one conversation, one consent, one girl found at home. Three doses means finding the same girl twice more, months apart, in a district where families move for work.

The part that should bother us

Zimbabwe has been putting health workers on bicycles since independence in 1980, and 45,923 community health workers have received one since 2009, most of them through the American charity World Bicycle Relief. The charity's own material says a bicycle lets a health worker reach up to 88 per cent more patients — a number published by the organisation that donates the bicycles, and worth reading as such.

The bicycles came at scale. The money never did. Village health workers in Zimbabwe are paid inconsistently, often through allowances that arrive from development partners rather than the state, sometimes late, sometimes not at all. Itai Rusike of the Community Working Group on Health has been blunt about where those allowances belong: in the national budget, not in someone else's grant cycle. The WHO's own 2018 guideline on community health worker programmes says the same thing in colder language — remunerate them commensurately with the demands of the job, don't pay them mainly in performance bonuses — and it notes that leaning on volunteer labour sits badly with the international commitment to decent work.

A public health system found the cheapest available solution to a real problem, and it was cheap because the labour was already there, unpaid, and would have been there anyway.

Aubrey Sachikonye is forty-five, cycles in Kariba, and had both her own daughters vaccinated. She put it in a sentence that needs no editing: "We cycle for HPV because no angel from Japan or Europe will do it for our community." Kurehwa Majaivhana, sixty-five, raising two orphaned granddaughters, described the day the cyclists reached her homestead and immunised both girls. She called the workers guardian angels.

Both women are describing the same arrangement from opposite ends, and neither of them is wrong. The elephants really are the easy part. The hard part is that a girl in Kariba is now protected from a cancer she will never know she avoided, and the person who protected her may not be paid this month.

Sources: Tsitsi Bhobo, “In rural Zimbabwe, ‘vaccine cyclists’ brave heat, dust and elephants”, VaccinesWork, 5 February 2026 · Farai Shawn Matiashe, “Pedalling vaccines in rural Zimbabwe”, VaccinesWork, 6 September 2024 · WHO chief hails India as HPV campaign surpasses 8 million doses, 11 September 2026 · Scaling HPV vaccination in Africa to eliminate cervical cancer by 2030, The Lancet Global Health · KEN SHE single-dose HPV vaccination trial, Kenya · WHO guideline on community health worker programmes, 2018